BiVictriX identifies development lead for ADC cancer program
BiVictriX Therapeutics plc, an emerging biotechnology company applying a novel approach to develop next generation…
December 7, 2022 - 2 minutes
Antibody-drug conjugates
Check out the latest antibody-drug conjugate news. This section covers the latest updates on approvals, regulations, deals, and antibody–drug conjugate (ADC) technology.
SOTIO exercises option on ADC program
SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, has exercised its first…
November 30, 2022 - 2 minutes
AstraZeneca and Daiichi Sankyo’s Enhertu recommended for approval
AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) for patients…
November 18, 2022 - 3 minutes
Mablink Bioscience receives €31M series A funding for ADC pipeline
French biotech company Mablink Bioscience has raised €31 million ($30.3 million) in series A funding…
October 14, 2022 - 2 minutes
Trial starts for treatment of warm autoimmune hemolytic anemia
China-based Hutchmed has started a phase 2/3 trial of sovleplenib in adults with a disorder…
October 10, 2022 - 2 minutes
Araris Biotech closes $24M financing round for ADCs
Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate (ADC)-linker technology, today announced the…
October 5, 2022 - 2 minutes
Pheon Therapeutics launches with $68M in series A funding for treatment of solid tumors
Pheon Therapeutics launched today (September 28) following the closing of a $68 million series A…
September 28, 2022 - 3 minutes
Cartography Biosciences unearths cancer immunotherapy targets
Despite its meteoric growth in the last twenty years, cancer immunotherapy research is hamstrung by…
September 22, 2022 - 5 minutes
Synaffix and Emergence in $360M technology platform deal to develop ADCs
Dutch biotech Synaffix B.V. and German Emergence Therapeutics announced today (September 6) they have entered…
September 6, 2022 - 2 minutes
CSL gets positive results for preventive treatment in patients with hereditary angioedema
Hereditary angioedema (HAE), a condition that causes recurrent attacks of severe swelling, could be prevented…
August 18, 2022 - 3 minutes
Mersana Therapeutics announces collaboration with GSK for the co-development of cancer treatment
A global collaboration was announced today (August 9) between Mersana Therapeutics Inc and GSK plc…
August 9, 2022 - 3 minutes
Formulations of Arecor Therapeutics’ drug to treat inflammatory diseases granted patents
Formulations of a drug that can help a number of inflammatory diseases including rheumatoid arthritis…
August 9, 2022 - 3 minutes
